{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T10:31:30Z","timestamp":1726482690113},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1007\/s11910-001-0034-6","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T11:02:52Z","timestamp":1180695772000},"page":"299-302","source":"Crossref","is-referenced-by-count":16,"title":["Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis"],"prefix":"10.1007","volume":"1","author":[{"given":"Randall T.","family":"Schapiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"34_CR1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1056\/NEJM198906083202310","volume":"320","author":"RR Young","year":"1989","unstructured":"Young RR: Treatment of spastic paresis. N Engl J Med 1989, 320:1553\u20131555.","journal-title":"N Engl J Med"},{"key":"34_CR2","first-page":"299","volume-title":"Multiple Sclerosis Diagnosis, Medical Management, and Rehabilitation","author":"RR Young","year":"2000","unstructured":"Young RR: Spastic paresis. In Multiple Sclerosis Diagnosis, Medical Management, and Rehabilitation. Edited by Burks JS, Johnson KP. New York: Demos Medical Publishing; 2000:299\u2013306. This is an overview of spasticity in multiple sclerosis, with a review of physiology and management."},{"issue":"suppl 9","key":"34_CR3","first-page":"S12","volume":"44","author":"RR Young","year":"1994","unstructured":"Young RR: Spasticity: a review. Neurology 1994, 44(suppl 9):S12\u201320.","journal-title":"Neurology"},{"issue":"suppl 1","key":"34_CR4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1177\/0883073896011001S02","volume":"11","author":"FM Filloux","year":"1996","unstructured":"Filloux FM: Neuropathophysiology of movement disorders in cerebral palsy. J Child Neurol 1996, 11(suppl 1):S5-S12.","journal-title":"J Child Neurol"},{"key":"34_CR5","first-page":"1","volume":"1","author":"WL Olson Jr","year":"1999","unstructured":"Olson Jr WL, Abrams BM: Management of spasticity in neurological disorders. Progress in Neurology 1999, 1:1\u201319. This is a very thorough review of all forms of spasticity with many references. It involves physiology and neurochemistry.","journal-title":"Progress in Neurology"},{"key":"34_CR6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.57.7.773","volume":"57","author":"P Brown","year":"1994","unstructured":"Brown P: Pathophysiology of spasticity. J Neurol Neurosurg Psychiatry 1994, 57:773\u2013777.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR7","unstructured":"Paty DW, Ebers GC: Clinical Features in Multiple Sclerosis. Philadelphia: FA Davis;"},{"key":"34_CR8","first-page":"540","volume":"192","author":"B Ashworth","year":"1964","unstructured":"Ashworth B: Preliminary trial of corisprodol in multiple sclerosis. Practitioner 1964, 192:540\u2013542.","journal-title":"Practitioner"},{"key":"34_CR9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0141-5425(84)90003-7","volume":"6","author":"T Vajd","year":"1984","unstructured":"Vajd T, Vodovnik L: Pendulum testing of spasticity. J Biomed Eng 1984, 6:9\u201316.","journal-title":"J Biomed Eng"},{"key":"34_CR10","first-page":"79","volume":"14","author":"L Bianchi","year":"1999","unstructured":"Bianchi L, Monaldi F, Paolucci S, et al.: Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin. Funct Neurol 1999, 14:79\u201392.","journal-title":"Funct Neurol"},{"key":"34_CR11","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","volume":"6","author":"JM Gracies","year":"1997","unstructured":"Gracies JM, Nance P, Eolvic E, et al.: Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl 1997, 6:S92\u2013120.","journal-title":"Muscle Nerve Suppl"},{"key":"34_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000114906","volume":"16","author":"W Cendrowski","year":"1977","unstructured":"Cendrowski W, Sobazyk M, Olson WL: Clonazapam, baclofen and placebo in the treatment of spasticity. Eur Neurol 1977, 16:275\u2013262.","journal-title":"Eur Neurol"},{"key":"34_CR13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"RD Penn","year":"1989","unstructured":"Penn RD, Savoy SM, Corcos E, et al.: Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989, 320:1517\u20131521.","journal-title":"N Engl J Med"},{"key":"34_CR14","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1185\/03007998809111122","volume":"10","author":"A Bes","year":"1988","unstructured":"Bes A, Eyssette M, Pierrot-Deseilligny E, et al.: A multi-centre, double blind trial of tizanidine, a new antispastic agent in spasticity associated with hemiplegia. Curr Med Res Opin 1988, 10:709\u2013718.","journal-title":"Curr Med Res Opin"},{"key":"34_CR15","first-page":"241","volume":"15","author":"L Groves","year":"1998","unstructured":"Groves L, Shellenberger MK, Davis CS: Tizanidine treatment of spasticity: a meta-analysis of controlled double-blind, comparative studies with baclofen and diazepam. Adv Ther 1998, 15:241\u2013251.","journal-title":"Adv Ther"},{"key":"34_CR16","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0003-9993(97)90168-4","volume":"78","author":"ME Mueller","year":"1997","unstructured":"Mueller ME, Gruenthal M, Olson WL, Olson WH: Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis. Arch Phys Med Rehabil 1997, 78:521\u2013524.","journal-title":"Arch Phys Med Rehabil"},{"key":"34_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00002060-199809000-00020","volume":"77","author":"A Dunevsky","year":"1998","unstructured":"Dunevsky A, Perel AB: Gabapentin for relief of spasticity associated with multiple sclerosis. Am J Phys Med Rehabil 1998, 77:451\u2013454.","journal-title":"Am J Phys Med Rehabil"},{"key":"34_CR18","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/sj.sc.3100481","volume":"35","author":"M Gruenthal","year":"1997","unstructured":"Gruenthal M, Mueller M, Olson WL, et al.: Gabapentin for the treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997, 35:686\u2013689.","journal-title":"Spinal Cord"},{"key":"34_CR19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0003-9993(00)90135-7","volume":"81","author":"NC Cutter","year":"2000","unstructured":"Cutter NC, Scott DD, Johnson JC, Whiteneck G: Gabapentin effect of spasticity in multiple sclerosis: a placebo-controlled, randomized trial. Arch Phys Med Rehabil 2000, 81:164\u2013169.","journal-title":"Arch Phys Med Rehabil"},{"key":"34_CR20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/jnnp.68.6.707","volume":"68","author":"N Hyman","year":"2000","unstructured":"Hyman N, Barnes M, Bhakta B, et al.: Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomized, double blind, placebo controlled, dose ranging study; J Neurol Neurosurg Psychiatry 2000, 68:707\u2013712.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ana.410280407","volume":"28","author":"BJ Snow","year":"1990","unstructured":"Snow BJ, Tsui JK, Bhatt MH, et al.: Treatment of spasticity with botulinum toxin: a double blind study. Ann Neurol 1990, 28:512\u2013515.","journal-title":"Ann Neurol"},{"issue":"suppl 3","key":"34_CR22","first-page":"12","volume":"6","author":"RG Pertwee","year":"1999","unstructured":"Pertwee RG: Cannabis and cannabinoids: pharmacology and rationale for clinical use. Forsch Komplementarmed 1999, 6(suppl 3):12\u201315.","journal-title":"Forsch Komplementarmed"},{"key":"34_CR23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","volume":"6","author":"RG Pertwee","year":"1999","unstructured":"Pertwee RG: Pharmacology of cannabinoid receptor ligands. Curr Med Chem 1999, 6:635\u2013664.","journal-title":"Curr Med Chem"},{"key":"34_CR24","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneur.1984.04050230052017","volume":"41","author":"DB Clifford","year":"1984","unstructured":"Clifford DB, Trotter JL: Pain in multiple sclerosis. Arch Neurol 1984, 41:1270\u20131272.","journal-title":"Arch Neurol"},{"key":"34_CR25","first-page":"97","volume":"16","author":"A Indaco","year":"1994","unstructured":"Indaco A, Iachetta C, Socci L, Carrieri PB: Chronic and acute pain syndromes in patients with multiple sclerosis. Acta Neurol 1994, 16:97\u2013102.","journal-title":"Acta Neurol"},{"key":"34_CR26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0404.1991.tb04937.x","volume":"84","author":"E Stenager","year":"1991","unstructured":"Stenager E, Knudsen I, Jensen K: Acute and chronic pain syndromes in multiple sclerosis. Acta Neurol Scand 1991, 84:197\u2013200.","journal-title":"Acta Neurol Scand"},{"key":"34_CR27","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1212\/WNL.38.12.1830","volume":"38","author":"Moulin","year":"1988","unstructured":"Moulin, Foley K, Ebers G: Pain syndromes in multiple sclerosis. Neurology 1988, 38:1830\u20131834.","journal-title":"Neurology"},{"key":"34_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archneur.1992.00530270069020","volume":"49","author":"M Ramirez-Lassepas","year":"1992","unstructured":"Ramirez-Lassepas M, Tulloch J, Quinones M, Snyder B: Acute radicular pain as a presenting symptom in multiple sclerosis. Arch Neurol 1992, 49:255\u2013258.","journal-title":"Arch Neurol"},{"key":"34_CR29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/WNL.49.1.304","volume":"49","author":"LM Samkoff","year":"1997","unstructured":"Samkoff LM, Daras M, Tuchman AJ, Koppel BS: Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin. Neurology 1997, 49:304\u2013305.","journal-title":"Neurology"},{"key":"34_CR30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/135245859700300407","volume":"3","author":"MK Koutchens","year":"1997","unstructured":"Koutchens MK, Richert JR, Sami A: Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997, 3:250\u2013253.","journal-title":"Mult Scler"},{"key":"34_CR31","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1212\/WNL.48.6.1714","volume":"48","author":"G Lunaardi","year":"1997","unstructured":"Lunaardi G, Leandri M, Albano C, et al.: Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997, 48:1714\u20131717.","journal-title":"Neurology"},{"key":"34_CR32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0404.1982.tb03076.x","volume":"65","author":"TS Jensen","year":"1982","unstructured":"Jensen TS, Rasmussen P, Reske-Nielsene: Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand 1982, 65:182\u2013189.","journal-title":"Acta Neurol Scand"},{"key":"34_CR33","first-page":"27","volume-title":"The Diagnosis of Multiple Sclerosis","author":"DW Paty","year":"1984","unstructured":"Paty DW, Poser C: Clinical symptoms and signs of multiple sclerosis. In The Diagnosis of Multiple Sclerosis. Edited by Poser C. New York: Stuttgart:Thieme-Stratton; 1984:27\u201334."},{"key":"34_CR34","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/WNL.45.6.1097","volume":"45","author":"A Reder","year":"1995","unstructured":"Reder A, Arnason B: Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue. Neurology 1995, 45:1097\u20131100.","journal-title":"Neurology"},{"key":"34_CR35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/jnnp.33.4.528","volume":"33","author":"M Espir","year":"1970","unstructured":"Espir M, Millac P: Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). J Neurol Neurosurg Psychiatry 1970, 33:528\u2013531.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR36","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.51.2.611","volume":"51","author":"OA Khan","year":"1998","unstructured":"Khan OA: Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998, 51:611\u2013614.","journal-title":"Neurology"},{"key":"34_CR37","first-page":"367","volume":"78","author":"JG Golfino","year":"1993","unstructured":"Golfino JG, Shetter AG: Treatment of trigeminal neuralgia in multiple sclerosis patients using radiofrequency thermal rhizotomy and glycerol rhizotomy. J Neurosurg 1993, 78:367.","journal-title":"J Neurosurg"},{"key":"34_CR38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/jnnp.68.1.59","volume":"68","author":"G Broggi","year":"2000","unstructured":"Broggi G, Ferroli P, Franzini A, et al.: Microvascular decom pression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2000, 68:59\u201364.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"34_CR39","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.55.12.1524","volume":"55","author":"D Kondziolka","year":"1998","unstructured":"Kondziolka D, Perez B, Flickinger JC, et al.: Gamma Knife radiosurgery for trigeminal neuralgia: results and expectations. Arch Neurol 1998, 55:1524\u20131529.","journal-title":"Arch Neurol"},{"issue":"suppl 1","key":"34_CR40","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000056423","volume":"70","author":"D Urgosik","year":"1998","unstructured":"Urgosik D, Vymazal J, Vladyka V, Liscak R: Gamma knife treatment of trigeminal neuralgia: clinical and electrophysiological study. Sterotact Funct Neurosurg 1998, 70(suppl 1):200\u2013209.","journal-title":"Sterotact Funct Neurosurg"},{"key":"34_CR41","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1212\/WNL.38.12.1845","volume":"38","author":"C Brodeur","year":"1988","unstructured":"Brodeur C, Montplaisir J, Godbout R, Marinier R: Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988, 38:1845\u20131848.","journal-title":"Neurology"},{"key":"34_CR42","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.sc.3100909","volume":"37","author":"MT deMello","year":"1999","unstructured":"deMello MT, Poyares DL, Tufik S: Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions. Spinal Cord 1999, 37:634\u2013637.","journal-title":"Spinal Cord"},{"key":"34_CR43","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/1531-8257(200003)15:2<324::AID-MDS1020>3.0.CO;2-4","volume":"15","author":"VG Evidente","year":"2000","unstructured":"Evidente VG, Adler CH, Caviness JN, et al.: Amantidine is beneficial in restless legs syndrome. Mov Disord 2000, 15:324\u2013327.","journal-title":"Mov Disord"},{"key":"34_CR44","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000117350","volume":"30","author":"A Gehezzi","year":"1990","unstructured":"Gehezzi A, Montanini R, Basso PF, et al.: Epilepsy in multiple sclerosis. Eur Neurol 1990, 30:218\u2013223.","journal-title":"Eur Neurol"},{"key":"34_CR45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-510X(98)00322-0","volume":"162","author":"M Sakurai","year":"1999","unstructured":"Sakurai M, Kanazawa I: Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999, 162:162\u2013168.","journal-title":"J Neurol Sci"},{"key":"34_CR46","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/mds.870100403","volume":"10","author":"C Tranchant","year":"1995","unstructured":"Tranchant C, Bhatia K, Marsden C: Movement disorders in multiple sclerosis. Mov Disord 1995, 10:418\u2013423.","journal-title":"Mov Disord"},{"key":"34_CR47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0404.1996.tb00036.x","volume":"94","author":"T Posterb","year":"1996","unstructured":"Posterb T, McMonagle U, Buttner, et al.: Paroxysmal convergence spasm in multiple sclerosis. Acta Neurol Scand 1996, 94:35\u201337.","journal-title":"Acta Neurol Scand"},{"key":"34_CR48","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/bjo.80.2.187","volume":"80","author":"E Ezra","year":"1996","unstructured":"Ezra E: Paroxysomal superior rectus and levator palpebrae spasm: a unique presentation of multiple sclerosis. Br J Ophthalmol 1996, 80:187\u2013188.","journal-title":"Br J Ophthalmol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0034-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-001-0034-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-001-0034-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T03:59:26Z","timestamp":1683863966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-001-0034-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s11910-001-0034-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}